Appeal No. 2000-1779
Application No. 08/473,204
Appeal No. 1999-0399
Application No. 08/377,503
Claim 140 is illustrative of the subject matter on appeal41 and is reproduced
below:
1. An isolated polynucleotide that codes for a kainate-binding human EAA5
receptor, wherein said receptor is:
the human EAA5a receptor having the amino acid sequence of
residues 1-888 of SEQ ID NO:2;
the human EAA5b receptor having the amino acid sequence of
residues 1-888 of SEQ ID NO:2 except that residue 321 is arginine;
or
the human EAA5c receptor having the amino acid sequence of
residues 1-838 of SEQ ID NO:2 followed by Pro-Pro.
Claim 10 is limited to a recombinant DNA construct, wherein said construct
is plasmid pcDNAI/humEAA5a (ATCC 75296). Claim 17 is limited to a membrane
preparation derived from a cell transfected with a heterologous DNA that encodes
for EAA5a, EAA5b or EAA5c as described in claim 1 with the exception that the
EAA5c receptor instead of followed by two proline residues instead of the specific
“Pro-Pro” sequence of defined in claim 1.
40 Claim 1 was amended after final (Paper No. 36, received July 14, 1997). The
above reproduction of claim 1 includes this amendment.
41 We note the examiner’s clarification (Answer, page 4) of applicants’ Appendix of
appealed claims wherein the examiner states that “line 2 of claim 10, “7” should be
replaced with “9”.
39
Page: Previous 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Next
Last modified: November 3, 2007